Thierauf, Julia, Veit, Johannes A., Gruenow, Jennifer, Doescher, Johannes, Weissiger, Stephanie, Whiteside, Theresa, Beutner, Dirk, Plinkert, Peter, Hoffmann, Thomas K. and Hess, Jochen (2016). Expression of Submaxillary Gland Androgen-regulated Protein 3A (SMR3A) in Adenoid Cystic Carcinoma of the Head and Neck. Anticancer Res., 36 (2). S. 611 - 616. ATHENS: INT INST ANTICANCER RESEARCH. ISSN 1791-7530

Full text not available from this repository.

Abstract

Background: Adenoid cystic carcinoma of the head and neck (ACC) is a rare tumor entity which originates from the salivary glands. The prognosis remains poor, as the tumor tends to exhibit perineural invasion and frequently develops distant metastases. The submaxillary gland androgen-regulated protein 3A (SMR3A) belongs to a gene family producing opiorphin homologs and is physiologically secreted by salivary glands. Expression of SMR3A has been identified as an unfavorable risk factor in survival of patients with squamous cell carcinoma in the head and neck, but its value as a prognostic biomarker for ACC has not been addressed. Materials and Methods: Tissue sections from primary ACC (n=86) and healthy glandular tissue as reference, were stained by immunohistochemistry. SMR3A expression levels were correlated with clinical and pathological features, including overall survival. Results: All patients had undergone surgery and 67 received adjuvant radiotherapy. The median disease-free survival (DFS) was 37 months and the median overall survival (OS) was 75 months. Prominent SMR3A expression in tumor cells was found in 24 of 86 patients (27,9%), and was inversely correlated with a male gender (p=0.009). There was no significant correlation between SMR3A expression and DFS, metastasis-free survival or OS. Conclusion: Our data demonstrate for the first time decreased levels of SMR3A in ACC compared to normal glandular tissue. These data suggest a context-dependent regulation of SMR3A expression in the pathogenesis of distinct subtypes of head and neck tumors, and support the assumption that detection of SMR3A expression serves as a surrogate for aberrant differentiation into mucosal-or glandular-like cells in ACC and head and neck squamous cell carcinoma.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Thierauf, JuliaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Veit, Johannes A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gruenow, JenniferUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Doescher, JohannesUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Weissiger, StephanieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Whiteside, TheresaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Beutner, DirkUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Plinkert, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hoffmann, Thomas K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hess, JochenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-285105
Journal or Publication Title: Anticancer Res.
Volume: 36
Number: 2
Page Range: S. 611 - 616
Date: 2016
Publisher: INT INST ANTICANCER RESEARCH
Place of Publication: ATHENS
ISSN: 1791-7530
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
SQUAMOUS-CELL CARCINOMA; HUMAN OPIORPHIN; SURVIVAL; MODELMultiple languages
OncologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/28510

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item